bioAffinity Technologies Statistics
Total Valuation
BIAF has a market cap or net worth of $8.90 million. The enterprise value is $7.23 million.
Important Dates
The last earnings date was Friday, May 8, 2026, before market open.
| Earnings Date | May 8, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BIAF has 4.49 million shares outstanding. The number of shares has increased by 492.83% in one year.
| Current Share Class | 4.49M |
| Shares Outstanding | 4.49M |
| Shares Change (YoY) | +492.83% |
| Shares Change (QoQ) | +0.54% |
| Owned by Insiders (%) | 5.07% |
| Owned by Institutions (%) | 4.89% |
| Float | 4.27M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.58 |
| Forward PS | 1.72 |
| PB Ratio | 2.49 |
| P/TBV Ratio | 5.75 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.28 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.36, with a Debt / Equity ratio of 0.38.
| Current Ratio | 1.36 |
| Quick Ratio | 1.19 |
| Debt / Equity | 0.38 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -265.14 |
Financial Efficiency
Return on equity (ROE) is -622.65% and return on invested capital (ROIC) is -184.95%.
| Return on Equity (ROE) | -622.65% |
| Return on Assets (ROA) | -107.12% |
| Return on Invested Capital (ROIC) | -184.95% |
| Return on Capital Employed (ROCE) | -242.89% |
| Weighted Average Cost of Capital (WACC) | -1.66% |
| Revenue Per Employee | $99,296 |
| Profits Per Employee | -$278,596 |
| Employee Count | 57 |
| Asset Turnover | 0.84 |
| Inventory Turnover | 64.93 |
Taxes
In the past 12 months, BIAF has paid $35,347 in taxes.
| Income Tax | 35,347 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -67.96% in the last 52 weeks. The beta is -1.19, so BIAF's price volatility has been lower than the market average.
| Beta (5Y) | -1.19 |
| 52-Week Price Change | -67.96% |
| 50-Day Moving Average | 2.62 |
| 200-Day Moving Average | 3.25 |
| Relative Strength Index (RSI) | 39.16 |
| Average Volume (20 Days) | 395,146 |
Short Selling Information
The latest short interest is 515,756, so 11.48% of the outstanding shares have been sold short.
| Short Interest | 515,756 |
| Short Previous Month | 542,083 |
| Short % of Shares Out | 11.48% |
| Short % of Float | 12.09% |
| Short Ratio (days to cover) | 0.04 |
Income Statement
In the last 12 months, BIAF had revenue of $5.66 million and -$15.88 million in losses. Loss per share was -$5.89.
| Revenue | 5.66M |
| Gross Profit | 1.87M |
| Operating Income | -11.56M |
| Pretax Income | -15.84M |
| Net Income | -15.88M |
| EBITDA | -10.99M |
| EBIT | -11.56M |
| Loss Per Share | -$5.89 |
Full Income StatementBalance Sheet
The company has $3.10 million in cash and $1.38 million in debt, with a net cash position of $1.72 million or $0.38 per share.
| Cash & Cash Equivalents | 3.10M |
| Total Debt | 1.38M |
| Net Cash | 1.72M |
| Net Cash Per Share | $0.38 |
| Equity (Book Value) | 3.66M |
| Book Value Per Share | 0.81 |
| Working Capital | 1.16M |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 572,700 |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 33.08%, with operating and profit margins of -204.29% and -280.57%.
| Gross Margin | 33.08% |
| Operating Margin | -204.29% |
| Pretax Margin | -279.95% |
| Profit Margin | -280.57% |
| EBITDA Margin | -194.17% |
| EBIT Margin | -204.29% |
| FCF Margin | n/a |
